Medindia LOGIN REGISTER
Medindia

Decrease in Air Pollution Improves Kidney Function: Study

by Angela Mohan on Feb 21 2022 7:06 PM

Decrease in Air Pollution Improves Kidney Function: Study
Improving air quality may help the kidneys, suggests a study.
"Long-term exposure to PM2.5 has been associated with declined kidney function. However, whether the association is causal remains unknown," said Co-author Yiqun Han, research associate in School of Public Health, Imperial College London.

In the study, published in the journal Health Data Science, the team conducted a quasi-experimental difference-in-difference analysis. They identified a strong linkage between the reduced PM2.5 with improved kidney function, Han added.

The researchers analyzed the demographic and laboratory records of 5,115 adults. They investigated the change in kidney function parameters between 2011 and 2015 according to the population’s long-term exposure to PM2.5 derived from an environmental database.

Kidney Function Parameters

The team found that a 10 Ig/m3 reduction in PM2.5 significantly improved multiple kidney function parameters. Glomerular filtration rate (GFR) increased by 0.42 mL/min/1.73m2, blood urea nitrogen (BUN) decreased by 0.38 mg/dL, and uric acid (UA) decreased by 0.06 mg/dL, respectively.

GFR is a test used to check how well the kidneys are working and further the progression of chronic kidney disease.

Advertisement
Air pollution is known to affect kidney function. Several studies have shown that exposure to bad air is associated with an increased chronic kidney disease-related morbidity and mortality. Exposure to PM2.5, even at relatively low concentrations, is a risk factor for a lower kidney function and a faster decline in kidney function.

Han suggested the need for rapid air quality improvement driven by the action.

Advertisement
Besides kidneys, reduction in air pollution may help improve "population health, including cardiorespiratory diseases, metabolic diseases, mental and neurological disorders, and indicators for non-fatal risks (e.g., medical expenditure and disability), in addition to kidney diseases," he said.

Source-Medindia


Advertisement